article has not abstract
Published in the journal: . PLoS Pathog 6(9): e32767. doi:10.1371/journal.ppat.1001057 Category: Opinion doi: https://doi.org/10.1371/journal.ppat.1001057
Bacterial pathogens have evolved extraordinary mechanisms to efficiently infect host organisms. A majority of these pathogens do so by delivering virulence factors into host cells, which act to dampen host defenses or utilize the host as a niche for replication. Although regulation of virulence factor expression by bacterial pathogens is a well known pathogenic mechanism [1], the concept of host-protective virulence factors is emerging. Recently, several strategies by which pathogens appear to be attenuating their own lethality towards host cells have been documented, suggesting that increased hostility and damage of host cells is not necessarily beneficial to the pathogen. Virulence is often defined as the ability of a pathogen to inflict damage on host cells, and the following discussion addresses the concept that increased virulence is not always beneficial to the pathogen, and moderating it to preserve host cells is a mechanism several pathogens use as part of their overall pathogenic strategy. This strategy is well known for obligate intracellular pathogens, but has become an emerging theme in extracellular and facultative intracellular bacteria.
Yersinia spp., Shigella flexneri, Helicobacter pylori, and diarrheagenic Escherichia coli are well known for their ability to kill host cells. For Yersinia, death of infected macrophages dampens cytokine release and enables the pathogen to propagate with minimal challenges from the immune system [2]. Two recent studies suggest that cytotoxicity caused by Yersinia species is tightly regulated. Yersinia pestis, the etiologic agent of plague, and gastroenteritis-inducing Yersinia pseudotuberculosis and Yersinia enterocolitica all encode a cytotoxic virulence factor called YopJ/P (YopJ in the two former species and YopP in the latter), which are translocated into infected cells via a type III secretion system (T3SS) [2], [3]. Altering the cytotoxicity of Y. pseudotuberculosis affects its virulence. Decreased secretion of YopJ was shown to enhance Y. pseudotuberculosis pathogenesis in vivo [4]. Similarly for Y. pestis, enhanced cytotoxicity results in decreased incidence of pneumonic plague in vivo [5]. Tight regulation of cytotoxicity by pathogenic Yersinia is an efficient virulence strategy. Increased apoptosis of infected immune cells decreases production of proinflammatory cytokines; however, some inflammation at the early stages of infection is thought to facilitate tissue damage necessary for movement of bacteria and infected cells to other sites of replication within the host [4].
Enteropathogenic Escherichia coli, enterohaemorrhagic E. coli (EPEC and EHEC, respectively), and Citrobacter rodentium are attaching and effacing (A/E) pathogens that cause severe diarrheagenic disease [6]. The ability of A/E pathogens to kill intestinal epithelial cells has been well documented [7]–[14]. The type III secreted (T3S) effector EspF has a role in host cell death by causing mitochondrial-dependent apoptosis [11], [15]. We recently found that the T3S effector EspZ modulates cytotoxicity towards host cells. An EPEC espZ mutant (ΔespZ) caused enhanced cytotoxicity in host cells when compared to the wild-type strain [16], which was surprising since the ΔespZ strain is severely attenuated for virulence in vivo [17]. EspZ acts in part through the host transmembrane glycoprotein CD98 to activate focal adhesion kinase (FAK)-based survival pathways (Figure 1) [16]. Others found that the T3S effector NleH also dampens apoptosis of EPEC-infected cells, but via interaction with a Bcl-2-related protein involved in the mitochondrial death pathway (Figure 1) [18]. Unlike EspZ, NleH is not essential for EPEC colonization and only moderately impacts on A/E pathogen disease in vivo [19], [20]; however, there are likely other host-protective virulence factors that act redundantly to NleH during EPEC infection.
Fig. 1. Strategies evolved by bacterial pathogens to restrain virulence. (A) EPEC injects effector proteins into intestinal epithelial cells (IECs) via a T3SS. EspF localizes to mitochondria and causes release of cytochrome c into the host cell cytosol, which results in apoptotic death of the host cells. NleH interacts with Bax inhibitor-1 (BI-1), which inhibits release of cytochrome c from mitochondria. EspZ interacts with CD98, which then stimulates phosphorylation of focal adhesion kinase (FAK) to promote survival. Localization of NleH and EspZ in host cells during early stages of EPEC infection is unclear and has been portrayed as shown for simplicity. (B) H. pylori injects virulence factors into gastric epithelial cells via a type IV secretion system in addition to secreting soluble toxins. VacA is an H. pylori–secreted toxin that enters cells by pinocytosis and penetrates intracellular endosome trafficking pathways. VacA causes release of cytochrome c from mitochondria of infected cells, thus mediating host cell apoptosis. CagA is a T4S virulence factor, which prevents both pinocytosis/trafficking and cytochrome c release by VacA. Functions of CagA are dependent on its phosphorylation state, not depicted here. (C) S. flexneri enters IECs from their basolateral surface and then resides in the cell cytoplasm. Prosurvival signaling is initiated by Nod1 activation of Rip2 signaling, which terminates in expression of pro-survival genes, including Bcl-2, via NFκB activation and nuclear translocation. Conversely, S. flexneri facilitates a decrease in the Bcl-2/Bnip3 ratio, which leads to CypD-mediated disruption of mitochondria and oxidative stress-induced necrotic cell death.
H. pylori causes apoptosis of infected gastric epithelial cells [21]. Apoptosis induction by H. pylori has been linked to a secreted toxin called VacA, which induces cytochrome c release from mitochondria (Figure 1) [22]. Recently, it was determined that VacA-mediated apoptosis is counteracted by a type IV secreted (T4S) protein called CagA by both blocking pinocytosis of VacA and inhibiting VacA-mediated cytochrome c release from mitochondria [23] (Figure 1). Interestingly, loss of CagA in a VacA+ H. pylori strain decreases bacterial colonization and the incidence of gastric hyperplasia, adenocarcinoma, and inflammation [24]. Similar to the aforementioned pathogens, H. pylori has evolved a delicate interplay between host-protective and -detrimental virulence factors that are able to fine-tune virulence while promoting their propagation.
S. flexneri, the etiologic agent of bacilliary dysentery, causes death of infected macrophages and epithelial cells [25]. Despite this, several host-protective strategies are employed by S. flexneri. The T3S effector OspE was recently found to enhance adhesion of infected host cells to the underlying extracellular matrix [26]. Whether OspE activates host cell survival pathways directly is unknown; however, its interaction with integrin-linked kinase inhibits sloughing of infected cells into the intestinal lumen [26], consequently preventing anoikis of Shigella-infected cells. An ospE mutant does not colonize as efficiently as wild-type S. flexneri in vivo; thus, OspE may enhance colonization by preventing premature release of infected cells [26]. Epithelial cells succumb to S. flexneri infection via necrotic cell death, which functions to release intracellular bacteria and enhance inflammation [25]. Interestingly, survival pathways involving Rip2/IKKβ/NFκB are activated early during infection, followed by mitochondrial dysfunction and necrotic cell death (Figure 1) [25]. The early expression of pro-survival genes may enable S. flexneri to postpone cell death in a similar manner to EPEC, thus ensuring greater bacterial load prior to dissemination. The mechanism(s) by which S. flexneri enhances NFκB-mediated pro-survival signals are unknown.
All of the above pathogens have evolved strategies to attenuate their own host-damaging virulence factors. In many of these scenarios, removal of host-protective mediators actually reduces pathogenicity of the bacteria. The observation that EPEC encodes a host-protective virulence factor that is essential for its pathogenesis suggests that protecting host cells may be a key to the pathogenic strategies of other bacterial pathogens. The concept of host-protective virulence factors is only just emerging, and we believe host-protective virulence factors will become more apparent in other pathogenic strategies and may become interesting targets to combat bacterial disease. Importantly, virulence phenotypes that appear counterintuitive should not be ignored. Future studies into pathogenic mechanisms of virulent bacteria will likely reveal important roles for effectors or regulatory mechanisms that help the host cell and promote bacterial pathogenesis.
1. MekalanosJJ
1992
Environmental signals controlling expression of virulence determinants in bacteria.
J Bacteriol
174
1
7
2. AepfelbacherM
TrasakC
RuckdeschelK
2007
Effector functions of pathogenic Yersinia species.
Thromb Haemost
98
521
529
3. MillsSD
BolandA
SoryMP
van der SmissenP
KerbourchC
1997
Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein.
Proc Natl Acad Sci U S A
94
12638
12643
4. BrodskyIE
MedzhitovR
2008
Reduced secretion of YopJ by Yersinia limits in vivo cell death but enhances bacterial virulence.
PLoS Pathog
4
e1000067
doi:10.1371/journal.ppat.1000067
5. ZaubermanA
TidharA
LevyY
Bar-HaimE
HalperinG
2009
Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague.
PLoS ONE
e5938
doi:10.1371/journal.pone.0005938
6. CroxenMA
FinlayBB
2010
Molecular mechanisms of Escherichia coli pathogenicity.
Nat Rev Microbiol
8
26
38
7. VallanceBA
DengW
JacobsonK
2003
Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium.
Infect Immun
71
3443
3453
8. VallanceBA
KnodlerLA
2002
Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection.
70
2070
2081
9. Abul-MilhM
WuY
LauB
LingwoodCA
Barnett FosterD
2001
Induction of epithelial cell death including apoptosis by enteropathogenic Escherichia coli expressing bundle-forming pili.
69
7356
7364
10. CraneJK
VezinaCM
2005
Externalization of host cell protein kinase C during enteropathogenic Escherichia coli infection.
Cell Death Differ
12
115
127
11. CraneJK
McNamaraBP
DonnenbergMS
Role of EspF in host cell death induced by enteropathogenic Escherichia coli.
Cell Microbiol
3
197
211
12. FlynnAN
BuretAG
Caspases-3, -8, and -9 are required for induction of epithelial cell apoptosis by enteropathogenic E. coli but are dispensable for increased paracellular permeability.
Microb Pathog
44
311
319
13. Barnett FosterD
Abul-MilhM
HuescaM
2000
Enterohemorrhagic Escherichia coli induces apoptosis which augments bacterial binding and phosphatidylethanolamine exposure on the plasma membrane outer leaflet.
68
3108
3115
14. CraneJK
MajumdarS
PickhardtDF3rd
1999
Host cell death due to enteropathogenic Escherichia coli has features of apoptosis.
67
2575
2584
15. NougayredeJP
2004
Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway.
6
1097
1111
16. ShamesSR
GuttmanJA
de HoogCL
LiY
The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signaling.
1322
1339
17. DengW
PuenteJL
GruenheidS
VallanceBA
Dissecting virulence: systematic and functional analyses of a pathogenicity island.
101
3597
3602
18. HemrajaniC
BergerCN
RobinsonKS
MarchesO
MousnierA
NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection.
107
3129
3134
19. Garcia-AnguloVA
ThomasNA
Regulation of expression and secretion of NleH, a new non-locus of enterocyte effacement-encoded effector in Citrobacter rodentium.
190
2388
2399
20. HemrajaniC
WilesS
GirardF
DennisA
Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut.
76
4804
4813
21. MossSF
CalamJ
AgarwalB
WangS
HoltPR
1996
Induction of gastric epithelial apoptosis by Helicobacter pylori.
Gut
498
501
22. GalmicheA
RassowJ
DoyeA
CagnolS
ChambardJC
The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release.
EMBO J
19
6361
6370
23. OldaniA
CormontM
HofmanV
ChiozziV
OregioniO
Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells.
5
e1000603
doi:10.1371/journal.ppat.1000603
24. FrancoAT
JohnstonE
KrishnaU
YamaokaY
IsraelDA
Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors.
Cancer Res
379
387
25. CarneiroLA
TravassosLH
SoaresF
TattoliI
MagalhaesJG
Shigella induces mitochondrial dysfunction and cell death in nonmyleoid cells.
Cell Host Microbe
123
136
26. KimM
OgawaM
FujitaY
YoshikawaY
NagaiT
Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment.
Nature
459
578
582
Zvyšte si kvalifikaci online z pohodlí domova
Nemáte účet? Registrujte se
Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.
